tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MDWD Stock Latest News

MediWound Launches Phase III Trial for EscharEx Targeting Venous Leg Ulcers
Company AnnouncementsMediWound Launches Phase III Trial for EscharEx Targeting Venous Leg Ulcers
11d ago
6K
MDWD
MediWound initiates the VALUE Global Phase III trial of EscharEx
PremiumThe Fly
MediWound initiates the VALUE Global Phase III trial of EscharEx
11d ago
MDWD
Mediwound Advances in Enzymatic Therapeutics with Strategic Expansions
PremiumCompany Announcements
Mediwound Advances in Enzymatic Therapeutics with Strategic Expansions
2M ago
6K
MDWD
MediWound Approves 2024 Share Incentive Plan to Boost Employee Engagement
PremiumCompany Announcements
MediWound Approves 2024 Share Incentive Plan to Boost Employee Engagement
2M ago
6K
MDWD
MediWound to host virtual KOL event to discuss EscharEx Phase III VALUE study
PremiumThe Fly
MediWound to host virtual KOL event to discuss EscharEx Phase III VALUE study
2M ago
MDWD
MediWound Executives Acquire 18,462 Shares, Signaling Confidence in Company’s Future
PremiumCompany AnnouncementsMediWound Executives Acquire 18,462 Shares, Signaling Confidence in Company’s Future
2M ago
6K
MDWD
MediWound price target lowered to $25 from $28 at H.C. Wainwright
Premium
The Fly
MediWound price target lowered to $25 from $28 at H.C. Wainwright
3M ago
MDWD
MediWound Advances Enzymatic Therapeutics Amid Financial Shifts
Premium
Company Announcements
MediWound Advances Enzymatic Therapeutics Amid Financial Shifts
3M ago
MDWD
MediWound Advances with FDA Approval and New Funding
PremiumCompany Announcements
MediWound Advances with FDA Approval and New Funding
3M ago
6K
MDWD
MediWound reports Q3 EPS (98c), consensus (44c)
PremiumThe Fly
MediWound reports Q3 EPS (98c), consensus (44c)
3M ago
MDWD
MediWound to Discuss New Share Incentive Plan
PremiumCompany Announcements
MediWound to Discuss New Share Incentive Plan
3M ago
6K
MDWD
MDWD Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
MDWD Upcoming Earnings Report: What to Expect?
4M ago
MDWD
MediWound announces Phase II study evaluating EscharEx
PremiumThe FlyMediWound announces Phase II study evaluating EscharEx
5M ago
MDWD
MediWound files to sell 1.45M ordinary shares for holders
Premium
The Fly
MediWound files to sell 1.45M ordinary shares for holders
6M ago
MDWD
MediWound’s NexoBrid Gains FDA Pediatric Approval
Premium
Company Announcements
MediWound’s NexoBrid Gains FDA Pediatric Approval
6M ago
6K
MDWD
MediWound announces FDA approval for pediatric indication for NexoBrid
PremiumThe Fly
MediWound announces FDA approval for pediatric indication for NexoBrid
6M ago
MDWD
MediWound’s Financial Success and Growth
PremiumCompany Announcements
MediWound’s Financial Success and Growth
6M ago
6K
MDWD
MediWound’s Strategic Growth and Solid Q2 2024 Performance
PremiumCompany Announcements
MediWound’s Strategic Growth and Solid Q2 2024 Performance
6M ago
6K
MDWD
MediWound reports Q2 EPS (68c), consensus (42c)
PremiumThe Fly
MediWound reports Q2 EPS (68c), consensus (42c)
6M ago
MDWD
MediWound’s NexoBrid Triumphs in Burn Care Study
PremiumCompany AnnouncementsMediWound’s NexoBrid Triumphs in Burn Care Study
7M ago
6K
MDWD
MediWound announces results from NexoBrid Expanded Access Protocol
Premium
The Fly
MediWound announces results from NexoBrid Expanded Access Protocol
7M ago
MDWD
MDWD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MDWD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7M ago
MDWD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >